// App-Quantinova.ai

S2088 2015 AHA : The Effect of Cangrelor on Cardiovascular and Bleeding Events in Patients with Peripheral Artery Disease - Insights From CHAMPION PHOENIX

Researchers

Presenter

  • Robert A Harrington

Principal Investigators

  • Gregg W Stone

  • Deepak L Bhatt

  • Ph. Gabriel Steg

  • Michael C Gibson

  • Christian W Hamm

  • Matthew J Price

  • Jayne Prats

  • Efthymios N Deliargyris

  • Kenneth Mahaffey

  • Harvey D White

Medical Centers

  • Brigham & Women's Hospital, Boston, MA

  • GH Bichat Claude Bernard, Paris, France

  • Columbia University Medical Center, New York, NY

  • Scripps Clinic, La Jolla, CA.

  • Beth Israel Deaconess Medical Center, Boston, MA

  • Auckland City Hospital, Auckland, New Zealand

  • The Medicines Company, Parsippany, NJ

  • Kerckhoff Clinic, Bad Nauheim, Germany

Locations

  • United States

  • Germany

  • France

  • New Zealand

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Peripheral artery disease

  • Venous thrombosis

  • Coronary Artery Disease

Biomarkers

  • N/A

Drug/Treatment

  • Clopidogrel bisulfate

  • cangrelor

Outcome

  • N/A

Study Design

  • double blind/blinded

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved